T

Tango Therapeutics

Develops synthetic-lethality cancer therapies

Operational Excellence and Training Lead

Business OperationsConfirmed live in the last 24 hours
Full-timeBoston, MA, USA$164k - $246k

About the Job

Requirements

  • A bachelor's degree in Life Sciences or a related field is required.
  • Eight to ten or more years of experience in operational excellence, process improvement, training, or operational leadership within a regulated life sciences or clinical development environment.
  • Proven experience owning and implementing end-to-end processes or systems across multiple functions.
  • Hands-on experience designing and delivering process and role-based training.
  • Experience supporting audit and inspection readiness, including documentation and behavioral readiness.
  • Expertise in end-to-end process design, standardization, and optimization.
  • Knowledge of Lean and continuous improvement methodologies.
  • Expertise in training design, curriculum development, and adult learning principles.
  • Knowledge of process documentation, including standard operating procedures, guidance, and work instructions.
  • Experience with process performance metrics, key performance indicators, and dashboarding.
  • Understanding of compliance and inspection expectations in regulated environments.
  • Ability to translate strategy into execution as a systems thinker.
  • Ability to influence and drive adoption without direct authority.
  • Pragmatic change leadership and strong execution discipline.
  • A trusted-advisor mindset with credibility and accountability.

Responsibilities

  • Own and lead the end-to-end design, implementation, and optimization of assigned processes and systems across Development.
  • Translate strategic objectives into fit-for-purpose, standardized processes that are efficient, scalable, and inspection-ready.
  • Define process standards, guidance, and performance measures, ensuring clarity of roles and accountability.
  • Develop and deliver training on new or changed processes, including compliance expectations and inspection-readiness behavior.
  • Design and maintain role-based and process-based curricula, including onboarding.
  • Identify inefficiencies, risks, and variability through data analysis and stakeholder input, and lead targeted improvement initiatives.
  • Support functions in adopting new or improved processes through change management, training inputs, and practical guidance.
  • Ensure processes are well documented, consistently applied, and auditable to support inspection readiness.
  • Track and report process performance, improvement outcomes, and residual risks to Operational Excellence and Clinical Compliance leadership.
  • Act as a subject-matter expert and trusted advisor to functional teams on process excellence and operational rigor.
  • Support leadership in defining and executing the learning and capability-building strategy for Development functions.
  • Support leadership in building a learning culture that reinforces accountability, consistency, and continuous improvement.

Desired Qualifications

  • An advanced degree, such as an MBA or MSc.
  • Certification or formal training in Operational Excellence, Lean, Six Sigma, or Process Improvement.
  • Collaborative, service-oriented, and improvement-focused approach.

About the Company

Tango Therapeutics

Develops synthetic-lethality cancer therapies

Tango Therapeutics develops cancer medicines by leveraging synthetic lethality to selectively kill cancer cells while sparing healthy cells. Its approach focuses on creating drugs that exploit interactions between gene pairs, aiming for targeted therapies that spare normal tissue. The company advances its treatments through a strong R&D program and collaborates with larger pharmaceutical partners, such as Gilead Sciences, to co-develop therapies and accelerate commercialization. Revenue comes from these partnerships and funding rounds like its Series B. Tango differentiates itself with a dedicated emphasis on genetically targeted cancer therapies, a robust pipeline, and leadership that guides strategic collaborations. The company’s goal is to bring next-generation, genetically targeted immunotherapies to market, improving outcomes for cancer patients by precisely targeting tumor biology.

Company size
51-200
Company stage
IPO
Headquarters
Boston, MA
Founded
2017

Recently Posted Jobs

Explore more opportunities at Tango Therapeutics

See more jobs